Quarter Financials
Ovid Therapeutics Inc. (OVID)
$3.64
-0.20 (-5.21%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Net Income | -12 | -12 | -15 | -16 | -26 | -11 | -16 | 176 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -226 | -214 | -202 | -187 | -171 | -145 | -134 | -118 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Capital Expenditure | -0 | -0 | -1 | -0 | -0 | -0 | -0 | -0 |
|---|
| Net PPE | 16 | 16 | 17 | 16 | 0 | 0 | 0 | 0 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| New Purchases | - | - | - | - | - | - | -29 | -64 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|